Opportunity Information: Apply for CDC RFA GH20 2127

This funding opportunity, titled "Strengthen the Capacity of Republican Narcology Center of Kyrgyzstan on Practical Applications of Medication Assisted Treatment (MAT) Programs under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a CDC cooperative agreement (Funding Opportunity Number: CDC RFA GH20 2127) focused on improving HIV-related outcomes among people who inject drugs (PWID) in Kyrgyzstan by expanding and strengthening Medication Assisted Treatment (MAT) services. It sits under the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (specifically CGH), and is categorized as discretionary health funding under CFDA 93.067. The program is designed as a single award (Expected Awards: 1), indicating CDC planned to fund one primary recipient to lead or coordinate the work described.

The core purpose of the NOFO is to build the capacity of Kyrgyzstan's Republican Narcology Center (RNC) to deliver practical, higher-quality MAT programming and to connect MAT more directly to HIV treatment and tuberculosis (TB) services. In practical terms, the CDC is aiming for MAT to function not just as a standalone substance use intervention, but as a key entry point and retention tool for HIV care among PWID, a population that often faces barriers to consistent treatment due to stigma, legal issues, unstable living situations, and co-occurring health needs. The overarching health goals are threefold: increase access to and quality of MAT for PWID; increase enrollment and retention in antiretroviral therapy (ART) for people living with HIV (PLHIV) within PWID communities; and ultimately raise viral suppression rates among these patients. The emphasis on viral suppression reflects the broader HIV strategy of reducing illness and deaths while also lowering onward HIV transmission.

A major component of the opportunity is improving how services connect across the health system. The NOFO highlights strengthening promotion and active linkage pathways so that PWID who are already seen at ART and TB sites are proactively referred and connected to MAT services rather than left to navigate the system on their own. Beyond referral, the opportunity also stresses expanding integrated service delivery, meaning more coordinated or co-located MAT and ART services where patients can more easily receive addiction treatment and HIV care together. This integration is intended to reduce drop-off between programs, improve adherence to ART, and stabilize patients through evidence-based treatment for opioid dependence, which in turn supports better HIV outcomes.

The opportunity explicitly includes expansion of MAT for PWID in prison settings, recognizing that incarceration is a frequent touchpoint for PWID and a setting where continuity of care is often disrupted. Supporting MAT in prisons can reduce withdrawal and relapse, lower overdose risk after release, and create a pathway into sustained treatment and HIV care in the community. In addition, the NOFO calls for targeted demand creation for MAT, which generally refers to outreach, education, and other strategies to increase acceptance and uptake of MAT among PWID, families, providers, and communities. This demand-side focus matters in contexts where misinformation about MAT, fear of registration or surveillance, stigma, and concerns about law enforcement can reduce willingness to enroll even when services exist.

Funding details reflect a somewhat unusual presentation in the posted fields: the "Award Ceiling for Year 1" is listed as 0 (none), while CDC simultaneously anticipated an approximate total fiscal year funding amount of $500,000 for Year 1, contingent on funds being available. Read plainly, the listing suggests CDC planned to make about one award at roughly that level in the first year, but did not set a formal per-award cap in the ceiling field. The instrument type is a cooperative agreement, which typically means CDC expected to have substantial involvement beyond simply issuing funds, such as providing technical guidance, collaboration on implementation approaches, and ongoing performance monitoring.

Key administrative details include a creation date of February 21, 2020, and an original closing date of April 21, 2020. Applications were required to be submitted electronically by 11:59 p.m. Eastern Time on the due date. Eligibility is broadly labeled as "Others," with the specific eligibility criteria referenced as being described in the opportunity's additional eligibility text (not included in the excerpt). Overall, the opportunity is best understood as a targeted PEPFAR-supported effort to strengthen national MAT leadership and implementation through the Republican Narcology Center, while simultaneously improving HIV treatment uptake, retention, and viral suppression among PWID by integrating addiction treatment with ART and TB services and extending coverage to prison populations.

  • The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthen the Capacity of Republican Narcology Center of Kyrgyzstan on Practical Applications of Medication Assisted Treatment (MAT) Programs under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
  • This funding opportunity was created on Feb 21, 2020.
  • Applicants must submit their applications by Apr 21, 2020 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for CDC RFA GH20 2127

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title of this funding opportunity?

The opportunity is titled "Strengthen the Capacity of Republican Narcology Center of Kyrgyzstan on Practical Applications of Medication Assisted Treatment (MAT) Programs under the President's Emergency Plan for AIDS Relief (PEPFAR)."

What is the Funding Opportunity Number (NOFO number)?

The Funding Opportunity Number is CDC RFA GH20 2127.

Which U.S. agency is offering this opportunity?

This is a U.S. Department of Health and Human Services opportunity administered by the Centers for Disease Control and Prevention (CDC), under CDC's Center for Global Health (CGH).

What type of funding mechanism is being used?

The award mechanism is a cooperative agreement, which typically indicates CDC expects substantial involvement such as technical guidance, collaboration on implementation approaches, and performance monitoring.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.067.

How is this opportunity categorized?

It is described as discretionary health funding.

What country and health system does the work focus on?

The work focuses on Kyrgyzstan, with an emphasis on strengthening the capacity of Kyrgyzstan's Republican Narcology Center (RNC).

Who is the primary population this program aims to serve?

The program targets people who inject drugs (PWID) in Kyrgyzstan, particularly in the context of HIV prevention and treatment outcomes.

What is the primary purpose of the NOFO?

The purpose is to build the capacity of the Republican Narcology Center (RNC) to deliver practical, higher-quality Medication Assisted Treatment (MAT) programming and to connect MAT more directly to HIV treatment and tuberculosis (TB) services.

What are the main health goals described in the opportunity?

The opportunity emphasizes three main goals: (1) increasing access to and quality of MAT for PWID; (2) increasing enrollment and retention in antiretroviral therapy (ART) for people living with HIV (PLHIV) within PWID communities; and (3) increasing viral suppression rates among these patients.

How is MAT positioned within the HIV response in this opportunity?

MAT is framed not only as a substance use intervention, but as a key entry point into HIV care and a tool to improve retention in HIV treatment for PWID who face barriers like stigma, legal issues, unstable living situations, and co-occurring health needs.

What service integration does the NOFO emphasize?

The NOFO highlights strengthening promotion and active linkage pathways between MAT and ART/TB services, and expanding integrated service delivery so patients can more easily access addiction treatment and HIV care in a coordinated or co-located way.

What does the opportunity say about referrals and linkage to MAT?

It specifically calls for proactive referral and connection to MAT for PWID who are already being seen at ART and TB sites, rather than leaving patients to navigate the system on their own.

Does the opportunity include activities related to tuberculosis (TB) services?

Yes. The NOFO stresses connecting MAT more directly to TB services, including strengthening linkage pathways for PWID engaged in TB-related care.

Does the opportunity include work in prison settings?

Yes. The NOFO explicitly includes expansion of MAT for PWID in prison settings and recognizes incarceration as a frequent touchpoint where continuity of care is often disrupted.

Why does the NOFO emphasize MAT in prisons?

Based on the description, prison-based MAT is highlighted as a way to support continuity of care, reduce withdrawal and relapse, lower overdose risk after release, and create pathways into sustained treatment and HIV care in the community.

What is meant by "demand creation" for MAT in this opportunity?

The NOFO calls for targeted demand creation for MAT, described as outreach, education, and other strategies to increase acceptance and uptake of MAT among PWID, families, providers, and communities.

What barriers to MAT uptake does the opportunity recognize?

The description notes barriers such as misinformation about MAT, fear of registration or surveillance, stigma, and concerns about law enforcement, all of which can reduce willingness to enroll even when services are available.

How many awards did CDC expect to make?

The opportunity is described as a single award program, with Expected Awards listed as 1.

What was the anticipated funding amount for Year 1?

CDC anticipated approximately $500,000 in total fiscal year funding for Year 1, contingent on funds being available.

Why does the listing show an Award Ceiling for Year 1 as 0 (none)?

The posted fields list the "Award Ceiling for Year 1" as 0 (none) while also stating an anticipated approximate total funding of $500,000 for Year 1. Read plainly, this suggests CDC did not set a formal per-award cap in the ceiling field but still anticipated funding at roughly that level for the single award, subject to available funds.

When was the opportunity created and when did it close?

The creation date is February 21, 2020, and the original closing date is April 21, 2020.

What was the application submission deadline time and time zone?

Applications were required to be submitted electronically by 11:59 p.m. Eastern Time on the due date.

How were applications required to be submitted?

Applications were required to be submitted electronically.

Who was eligible to apply?

Eligibility is labeled broadly as "Others," with the note that specific eligibility criteria were described in the opportunity's additional eligibility text (which is not included in the provided excerpt).

What is the role of the Republican Narcology Center (RNC) in this opportunity?

The RNC is the central capacity-building focus of the NOFO. The award is intended to strengthen RNC's ability to deliver practical, higher-quality MAT services and improve how MAT connects with HIV and TB services.

How does the opportunity align with PEPFAR?

The opportunity is described as a PEPFAR-supported effort aimed at improving HIV outcomes among PWID, including ART enrollment/retention and viral suppression, by strengthening and expanding MAT and integrating it with HIV and TB services.

Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH

Browse more opportunities from the same category: Health

Next opportunity: 2020 Diesel Emissions Reduction Act (DERA) Tribal Grants

Previous opportunity: Cooperative Ecosystem Studies Unit, South Florida Caribbean CESU

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH20 2127

 

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH20 2127) also looked into and applied for these:

Funding Opportunity
Acceleration towards Epidemic Control of Comprehensive HIV, TB and Related Infections including Prevention, Treatment and Retention of Prisoners and Staff of Uganda Prisons Service (UPS) under the President's Emergency Plan for AIDS Relief (PEPF Apply for CDC RFA GH20 2067

Funding Number: CDC RFA GH20 2067
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Research Grants to Prevent Firearm-Related Violence and Injuries (R01) Apply for RFA CE 20 006

Funding Number: RFA CE 20 006
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $650,000
Minority Research Grant Program Apply for CMS 1W1 20 001

Funding Number: CMS 1W1 20 001
Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $250,000
National Human Resources for Health (HRH) Strategic Support, Advanced Health Care Worker Training, and Operationalization of a Local Laboratory External Quality Assurance System in Malawi under the President's Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH20 2047

Funding Number: CDC RFA GH20 2047
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Establishment of a Strategic Partnership to Strengthen the Council of Ministries of Health of Central America (COMISCA) in Central America (CA) and the Dominican Republic (DR) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2012

Funding Number: CDC RFA GH20 2012
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Improving Quality of Care and Health Impact through Innovative Systems and Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2081

Funding Number: CDC RFA GH20 2081
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
National Center of Excellence for the Prevention of Childhood Agricultural Injury Apply for RFA OH 20 007

Funding Number: RFA OH 20 007
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $1,500,000
Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional) Apply for RFA AG 21 016

Funding Number: RFA AG 21 016
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $700,000
Support the Strengthening and Utilization of Strategic Information Activities in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2061

Funding Number: CDC RFA GH20 2061
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Conducting Public Health Research in Columbia Apply for RFA GH 20 003

Funding Number: RFA GH 20 003
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $2,000,000
Strengthen the Capacity of Republican Narcology Center of Tajikistan on Practical Applications of Medication-Assisted Treatment (MAT) Programs under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2128

Funding Number: CDC RFA GH20 2128
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Improve and strengthen the Nigerian National Public Health Institutes management capacity and public health functions Apply for CDC RFA GH20 2098

Funding Number: CDC RFA GH20 2098
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Strengthening Global Field Epidemiology Training Program (FETP) Network Apply for CDC RFA GH20 2108

Funding Number: CDC RFA GH20 2108
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Building and Strengthening Public Health Systems, Impact, and Capacity in Indonesia through Partner Collaboration Apply for CDC RFA GH20 2120

Funding Number: CDC RFA GH20 2120
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Strengthening Global Health Security by implementation of the International Health Regulations (IHR) (2005) and the Global Health Security Agenda in Nigeria Apply for CDC RFA GH20 2126

Funding Number: CDC RFA GH20 2126
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Accelerating Sustainability of Public Health Systems in India to Prevent, Detect, and Respond to Infectious Disease Outbreaks and Other Public Health Emergencies Apply for CDC RFA GH20 2091

Funding Number: CDC RFA GH20 2091
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Childhood Lead Poisoning Prevention and Surveillance of Blood Lead Levels in Children Apply for CDC RFA EH20 2001

Funding Number: CDC RFA EH20 2001
Agency: Department of Health and Human Services, Centers for Disease Control - NCEH
Category: Health
Funding Amount: $1,000,000
Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH20 2110

Funding Number: CDC RFA GH20 2110
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Strengthening Laboratory Systems to Establish Routine Laboratory based surveillance for Priority Infectious Diseases in India Apply for CDC RFA GH20 2095

Funding Number: CDC RFA GH20 2095
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Tanzania Global Health Security Partner Engagement: Advancing Efforts and Strategies to Protect and Improve Public Health Apply for CDC RFA GH20 2101

Funding Number: CDC RFA GH20 2101
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH20 2127", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: